Myomo and GRE to Conduct Screening Days in Ohio and Detroit
February 14 2018 - 8:00AM
Business Wire
Free, Convenient Hands-on Trial of MyoPro®
Powered Brace
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a
commercial stage medical robotics company, and Geauga
Rehabilitation Engineering (GRE) have announced a series of free
screening days to be held at the offices of GRE and its local
partners near Cleveland, Detroit, Columbus and Cincinnati.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20180214005214/en/
MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to weakened or
paralyzed arms. (Photo: Business Wire)
At these events, certified MyoPro specialists will, at no
charge, evaluate patients suffering a weakened or paralyzed arm
from stroke, brachial plexus injury or other neuromuscular disease
or injury to determine whether the MyoPro powered orthosis might be
able to help restore function to that arm.
Myomo manufactures MyoPro and GRE is one of the Company’s
regional Centers of Excellence (COE) located across the country
that fit and deliver the device to patients.
“MyoPro braces are meeting an unmet need, and many patients are
excited to learn how this life-changing product can help them,”
said Myomo Chairman and CEO Paul R. Gudonis. “Staging these open
screening days allows patients to try on a MyoPro so they can see
for themselves how it might change their lives.”
Vince Baroni, Clinical Director of GRE, said “We piloted these
screening days last month to great reception from patients. Several
have already decided, with their doctors, that MyoPro is right for
them. We’re excited to continue leveraging this awareness
channel.”
Patients interested in trying a MyoPro at one of these screening
days may register online for a session near them:
Feb. 21, Columbus:
www.greop.com/free-evaluation-screening-columbus-2018Feb. 22,
Cleveland:
www.greop.com/free-evaluation-screening-cleveland-2018Feb. 23,
Detroit: www.greop.com/free-evaluation-screening-detroit-2018Feb.
28, Cincinnati:
www.greop.com/free-evaluation-screening-cincinnati-2018
Myomo is working with other MyoPro COEs across the country to
organize similar screening days in their service areas.
About Myomo
Myomo, Inc. is a commercial stage medical robotics company that
offers expanded mobility for those suffering from neurological
disorders and upper limb paralysis. Myomo develops and markets the
MyoPro product line. MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to the weakened or
paralyzed arms of patients suffering from CVA stroke, brachial
plexus injury, traumatic brain or spinal cord injury, ALS or other
neuromuscular disease or injury. It is currently the only marketed
device that, sensing a patient’s own EMG signals through
non-invasive sensors on the arm, can restore an individual’s
ability to perform activities of daily living, including feeding
themselves, carrying objects and doing household tasks. Many are
able to return to work, live independently and reduce their cost of
care. Myomo is headquartered in Cambridge, Massachusetts, with
sales and clinical professionals across the U.S. For more
information, please visit www.myomo.com.
Forward Looking Statements
This press release contains forward-looking statements regarding
the Company's future business expectations, which are subject to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are only
predictions and may differ materially from actual results due to a
variety of factors. Our actual results could differ materially from
those anticipated in these forward looking statements for many
reasons, including, without limitation, risks related to regulatory
approval and market acceptance of our products, and the other risk
factors contained in our filings made with the Securities and
Exchange Commission. More information about factors that
potentially could affect Myomo's financial results is included in
Myomo's filings with the Securities and Exchange Commission. The
Company cautions readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made.
The Company disclaims any obligation subsequently to revise any
forward-looking statements to reflect events or circumstances after
the date of such statements or to reflect the occurrence of
anticipated or unanticipated events.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180214005214/en/
For Myomo:ir@myomo.comorInvestor Relations:PCG
AdvisoryVivian Cervantes,
212-554-5482vivian@pcgadvisory.comorPublic
Relations:GreenoughRachel Robbins,
617-275-6521rrobbins@greenough.biz
Myomo (AMEX:MYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Apr 2023 to Apr 2024